Filter
469
Text search:
Delta
Featured
52
149
Language
Document type
190
95
88
23
23
19
15
6
3
2
2
2
1
Countries / Regions
53
44
31
20
12
12
10
8
8
6
6
5
5
5
4
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
257
17
14
11
10
9
6
1
Toolboxes
146
31
22
12
12
11
10
7
7
6
6
6
6
5
3
3
2
2
2
2
2
1
1
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
Today’s children, and their children, are the ones who will live with the consequences of climate change.
What near-term climate impacts should worry us most?
Supporting the most exposed and vulnerable societies to reduce
regional and global climate risks
Guia de procedimientos de bioseguridad para la consulta odontologica durant la pandemia por COVID-19
Guide to bio-safety procedures for dental practices during the COVID-19 pandemic
Updated Treatment Guidelines
Guidelines on Management of COVID-19 in Kenya
recommended
It has been over a year since Kenya identified the first case of COVID-19 in the country. The Government formed the National COVID-19 task force, which supported the country's response through multi-sectoral technical working groups on testing, case management, risk communication and community engag
...
Afr J Thoracic Crit Care Med 2021;27(4):Published online 22 October 2021. https://doi.org/10.7196/AJTCCM.2021.v27i4.173
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
Interconnected Disaster Risks is a new science-based report for the general public from United Nations University – Institute for Environment and Human Security. It was first published in 2021, and is set to become an annual report.
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re
...
Lancet Planet Health 2021; 5: e542–52
– (Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. 30 μg von BioNTech/Pfizer
...
Technical guidelines for the comprehensive care of patients with COVID-19 ; second version
Working towards better COVID-19 outcomes in the WHO European Region.From the first COVID-19 cases in Europe reported on
24 January 2020, the pandemic reached 1 million cases
within 3 months, 10 million cases within 8 months, and
100 million cases in Europe alone within 2 years. Over
the course o
...
COVID-19 Progress Report PAHO/WHO Argentina: 24 February 2022
Epidemiología; Resumen de puntos clave de conferencias y declaraciones de interés de OPS/OMS; Variantes de interés y preocupación; Actualización en vacunas; OPS/OMS en redes sociales; Publicaciones relacionadas; Noticias de la Regi
...
